Induced-pluripotent stem cells and neuroproteomics as tools for studying neurodegeneration

Biochem Soc Trans. 2024 Jan 30:BST20230341. doi: 10.1042/BST20230341. Online ahead of print.ABSTRACTThe investigation of neurodegenerative diseases advanced significantly with the advent of cell-reprogramming technology, leading to the creation of new models of human illness. These models, derived from induced pluripotent stem cells (iPSCs), facilitate the study of sporadic as well as hereditary diseases and provide a comprehensive understanding of the molecular mechanisms involved with neurodegeneration. Through proteomics, a quantitative tool capable of identifying thousands of proteins from small sample volumes, researchers have attempted to identify disease mechanisms by detecting differentially expressed proteins and proteoforms in disease models, biofluids, and postmortem brain tissue. The integration of these two technologies allows for the identification of novel pathological targets within the realm of neurodegenerative diseases. Here, we highlight studies from the past 5 years on the contributions of iPSCs within neuroproteomic investigations, which uncover the molecular mechanisms behind these illnesses.PMID:38288874 | DOI:10.1042/BST20230341
Source: Biochemical Society Transactions - Category: Biochemistry Authors: Source Type: research